- Levodopa, dopamine agonists, or MAO-B inhibitors are all first-choice options for initial pharmacotherapy in early Parkinson’s Disease.
- In later stages of Parkinson’s Disease, levodopa, dopamine agonists, MAO-B inhibitors, or COMT inhibitors are all options.